Literature DB >> 35079807

Reply to Koekkoek et al. concerning SNO and EANO practice guideline update.

Tobias Walbert1,2, Elizabeth R Gerstner3,4.   

Abstract

Entities:  

Year:  2022        PMID: 35079807      PMCID: PMC8917390          DOI: 10.1093/neuonc/noac015

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  3 in total

1.  First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.

Authors:  Pim B van der Meer; Linda Dirven; Marta Fiocco; Maaike J Vos; Mathilde C M Kouwenhoven; Martin J van den Bent; Martin J B Taphoorn; Johan A F Koekkoek
Journal:  Epilepsia       Date:  2021-03-18       Impact factor: 5.864

Review 2.  Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review.

Authors:  Marjolein E de Bruin; Pim B van der Meer; Linda Dirven; Martin J B Taphoorn; Johan A F Koekkoek
Journal:  Neurooncol Pract       Date:  2021-05-28

3.  SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.

Authors:  Tobias Walbert; Rebecca A Harrison; David Schiff; Edward K Avila; Merry Chen; Padmaja Kandula; Jong Woo Lee; Emilie Le Rhun; Glen H J Stevens; Michael A Vogelbaum; Wolfgang Wick; Michael Weller; Patrick Y Wen; Elizabeth R Gerstner
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.